MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 14, 2006; DOI: 10.1124/mol.106.026450


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.026450v1
70/5/1735    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grube, M.
Right arrow Articles by Kroemer, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grube, M.
Right arrow Articles by Kroemer, H. K.


Received for publication May 9, 2006.
Revised August 8, 2006.
Accepted for publication August 14, 2006.

Modification of OATP2B1 mediated transport by steroid hormones

Markus Grube 1, Kathleen Kock 1, Susanne Karner 1, Sebastian Reuther 1, Christoph A. Ritter 2, Gabriele Jedlitschky 1, Heyo K. Kroemer 1*

1 Dept. of Pharmacology, Ernst-Moritz-Arndt University Greifswald 2 Dept. of Pharmacology and Dept. of Pharmacy, Ernst-Moritz-Arndt University Greifswald

* Address correspondence to: E-mail: kroemer{at}uni-greifswald.de

Abstract

The family of the organic anion transporting polypeptides forms an increasing group of uptake transport proteins with a wide substrate spectrum. While the expression of some members of this group like OATP-A or C is limited to special tissues like liver or brain, the organic anion transporting polypeptide 2B1 (OATP-B / SLCO2B1) is expressed in many organs including liver, placenta, mammary gland, brain, and intestine. However, little is known about its function in those tissues, because only a limited number of compounds like dehydroepiandrosterone-sulfate (DHEAS) and estrone-3-sulfate (E3S) have been characterized as OATP2B1 substrates. To further elucidate the role of OATP2B1 on steroid transport, we examined the influence of steroid hormones on OATP2B1-mediated E3S and DHEAS uptake using OATP2B1-overexpressing MDCKII cells. We could identify unconjugated androgens (e.g. testosterone) as potent inhibitors for OATP2B1. In contrast, gestagenes like progesterone enhance E3S uptake in a concentration dependent manner to up to 300 % of the control, accompanied by a significant decrease in OATP2B1 Km value for E3S (control: Km = 14 µM; in the presence of 31.6 µM progesterone Km = 3.6 µM). Moreover, we could demonstrate that testosterone and progesterone are not substrates of OATP2B1, indicating an allosteric mechanism for the observed effects. Furthermore, we could show that progesterone enhances the OATP2B1-dependent pregnenolone sulfate transport. Taken together, the results indicate functional modification of OATP2B1-mediated E3S and DHEAS as well as pregnenolone sulfate transport through steroid hormones like progesterone. These effects can have physiological consequences for the organ-specific uptake of steroids.


Key words: Sex hormones, Organic anion, Liver transporters





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics